Elicio Therapeutics, Inc. · Brief

Next report

11 days

Nov 12 · after closeest.Q3 FY26

Expected move

±25.2%implied · report alone

1.262.10

straddle ±48.1%

spot 1.68exp Nov 20ATM strike 2.5ATM straddle 0.95IV 166%

Oct 30 closereport share · term structure

Expected move

—≥ implied

Q2 FY26±18.7%▼−1.90%×0.10

quarterimplied−20%0+20%realized×

Q2 FY26±18.7%▼−1.90%×0.10

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2 of 3

6disclosed supplier and customer ties in SEC filingsSEC filings

55managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear1

2 of 12of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

ELTX report session

No linked exposure.

Oct 29impliedImplied move: ±42.5% into Nov 12 earnings (Oct 29 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.